Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation

NCT04280237 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-04-29

No results posted yet for this study

Summary

This study describes Cefazolin pharmacokinetics variation to target levels during liver transplantation.

Conditions

  • Liver Transplant Infection
  • Surgical Site Infection
  • Antibiotic Prophylaxis
  • Cephazolin Adverse Reaction

Interventions

OTHER

Blood samples

Blood samples

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Anne-Charlotte TELLIER, MD · University Hospital, Tours

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2020-03-18
Completion
2020-03-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280237 on ClinicalTrials.gov